The week in charts: Pharma tariffs, core sectors reset, rural income
From 1 August, generic medicines will enter the US duty-free for two years, after which they will face escalating tariffs, raising concerns for India's pharmaceutical exports. India's core sector output grew 5% in June 2026, its fastest pace in five months, coinciding with the launch of a revamped Index of Core Industries. Meanwhile, rural households reported their weakest income momentum since September 2024, and domestic air passenger traffic has contracted after a brief recovery.